© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
June 23, 2022
Proposal follows announced ban on menthol cigarettes, flavored cigars, and e-cig ban could be coming.
June 22, 2022
Six are currently on the market and more are in the pipeline.
June 15, 2022
New options are being developed for conditions including psoriatic arthritis, ulcerative colitis, and asthma.
June 14, 2022
The pipeline includes next-in-class treatments for melanoma, NSCLC, breast cancer, and multiple myeloma.
May 16, 2022
Real-world study conducted in Japan shows Dupixent (dupilumab) reduced the number of annual severe asthma exacerbations by 53%, there were also adverse events associated with high eosinophil levels in patients who had switched from a different biologic before starting Dupixent.
May 13, 2022
Xolair (omalizumab), Fasenra (benralizumab), Dupixent (dupilumab) and Nucala (mepolizumab) can now be self-administered.
May 09, 2022
Pharmacists are essential for managing complex CF regimens, monitoring their effectiveness, and improving adherence.
May 03, 2022
This year’s theme is focused on raising awareness about current gaps in care.
April 20, 2022
E-cigarettes may be helpful for smoking cessation.
March 19, 2022
Keeping OTC products near the pharmacy counter creates an opportunity for patient counseling and education.